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Meningococci can cause clusters of disease.
Specimens from 1,616 patients in Germany obtained over
42 months were typed by serogrouping and sequence typ-
ing of PorA and FetA and yielded a highly diverse dataset
(Simpson’s index 0.963). A retrospective spatiotemporal
scan statistic (SaTScan) was applied in an automated fash-
ion to identify clusters for each finetype defined by
serogroup variable region (VR) VR1 and VR2 of the PorA
and VR of the FetA. A total of 26 significant clusters
(p<0.05) were detected. On average, a cluster consisted of
2.6 patients. The median population in the geographic area
of a cluster was 475,011, the median cluster duration was
4.0 days, and the proportion of cases in spatiotemporal
clusters was 4.2%. The study exemplifies how the combi-
nation of molecular finetyping and spatiotemporal analysis
can be used to assess an infectious disease in a large
European country.
I
nfection with meningococci in a susceptible human host
can involve septicemia and meningitis, which are
referred to as invasive meningococcal disease (IMD). IMD
generates public concern and panic because of its often
lethal outcome, its propensity to affect the young, and its
occasional appearance in clusters. Meningococci are high-
ly variable bacterial pathogens, as shown by a multitude of
different sequence types identified by multilocus sequence
typing (MLST) (1) and by antigen sequence typing of the
outer membrane proteins such as PorA (2) and FetA (3). 
Use of DNA sequence-based typing has several advan-
tages over serotyping: information is reproducible and
portable, most isolates are typeable, and culture-independ-
ent typing is possible. The consistent use of DNAsequence
typing at the German National Reference Center for
Meningococci (NRZM) since December 2001 has resulted
in an extensive database containing a large number of
unambiguously typed isolates. We define the term finetype
as the antigenic profile of a meningococcal strain consist-
ing of the serogroup, the sequence types of the variable
regions (VRs) VR1 and VR2 of the PorA, and the
sequence type of the immunodominant VR of FetA. The
European Monitoring Group on Meningococci recom-
mended in 2005 that PorA sequence typing be implement-
ed as a standard typing method in all participating
countries by 2007.
A meningococcal disease cluster is regarded as an
aggregation of cases caused by the same bacterial strain
closely grouped in space and time. While most cases of
IMD appear in a sporadic fashion in industrialized coun-
tries, coprimary (i.e., occurring within 24 hours) and sec-
ondary cases occur regularly (4), as shown in institutional
and household surveys (5). A community outbreak (6)
represents an excess of incidence in a defined geographic
area or population, in which direct links between cases are
not always readily apparent. In most instances, detection
of increases in case counts within defined spatial and tem-
poral boundaries, for lack of more objective methods,
must rely on the attentiveness of public health officials
(7). Computer-assisted spatiotemporal cluster analyses
might help identify and statistically evaluate increased
instances of meningococcal disease, thus providing valu-
able information for further public health investigation
and intervention.
Many methods have been developed for cluster analy-
sis (8). A stochastic model has been applied to predict out-
breaks of meningococcal disease in closed communities
such as military cohorts (9). Hoebe et al. used space-time
nearest neighbor analysis to statistically evaluate clusters
of IMD in the Netherlands (10). One of the most widely
used software packages for cluster analysis is SaTScan,
which was developed by Martin Kulldorff (National
Cancer Institute, Bethesda, MD, USA) and Farzad
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Hygiene, New York, NY, USA) (11). In infectious disease
epidemiology, SaTScan has been used to study listeriosis
(12), methicillin-resistant Staphylococcus aureus infection
(13), gonorrhea (14), West Nile fever (15), Creutzfeldt-
Jakob disease (16), bovine respiratory syncytial virus (17),
and pediatric pneumonia (18). Furthermore, national
bioterrorism syndromic surveillance (19) and public health
systems (20,21) rely on the use of this program. We
applied SaTScan to a rigorously typed strain collection to
identify and quantify finetype-specific clusters of cases of




Meningococcal strains and culture-negative specimens
obtained from patients with IMD are referred to NRZM
by regional laboratories and hospitals for finetyping and,
where applicable, antimicrobial drug resistance testing.
Data are managed at NRZM by using a Microsoft Access
database (Microsoft Corp., Redmond, WA, USA) that pro-
vides a user-friendly entry and retrieval surface. From
December 1, 2001, to June 1, 2005, meningococci were
detected from a normally sterile site in 1,828 patients;
1,616 patients with complete typing data and available
residential postcode were included in the analysis. In 46
(2.8%) of these 1,616 cases, only clinical material (i.e.,
cerebrospinal fluid or serum) was analyzed. Of the
remaining patients, no postcodes were available, no
meaningful geographic information could be extracted
from the postcode provided by the submitting laboratory,
or finetyping could not be performed. Although the first 2
causes were outside the realm of NRZM, the last cause
was mainly due to limitations of DNA sequence typing of
meningococcal DNA from native samples such as cere-
brospinal fluid or blood. Arecent capture-recapture analy-
sis for 2003 showed that NRZM processes samples from
≈65% of all cases estimated to occur in Germany (22).
Underreporting to the NRZM occurs because submission
of data by regional laboratories is voluntary, whereas
reporting to the Robert Koch-Institute is statutory. For
assessment of the systematic bias introduced by reporting
behavior, see Adjustment for Potential Confounders in the
Results section. 
During the time of the study, no general recommenda-
tion existed in Germany for serogroup C conjugate vacci-
nation. Two limited vaccination campaigns were initiated
after observation of clusters 11 and 19 reported herein
(Table).
Meningococcal Typing
Serogrouping of meningococcal isolates was accom-
plished by slide agglutination with monoclonal antibodies
NmA 932, NmB 735, NmW135 1509, and NmY 1938
(Chiron-Behring, Marburg, Germany) and Neisseria
meningitidis group C agglutinating sera (Remel, Lenexa,
KS, USA). Culture-independent genotyping of meningo-
cocci was performed by amplification of polysialyltrans-
ferase genes specific to the serogroups B, C, W-135, and Y
(23). Finetyping was accomplished by amplification and
DNAsequencing of VR1 and VR2 of the porA gene encod-
ing PorA and the VR of the fetA gene encoding the FetA
protein (2,3). A finetype is expressed by the antigenic pro-
file serogroup: P1.VR1,VR2:FVR1, where P1 is PorA and
F is FetA. Deduced amino acid sequences were compared
with entries in databases accessible at www.neisseria.org,
which is curated by Keith Jolley (Oxford, UK) and Ian
Feavers (Potters Bar, UK). Sequence data were analyzed
with LASERGENE sequence-analysis software (DNAS-
TAR, Madison, WI, USA) and TraceEdit Pro (Ridom,
Würzburg, Germany). 
DNA from culture-negative cerebrospinal fluid, blood,
or serum was extracted by using the QIAamp DNA blood
mini kit (Qiagen, Hilden, Germany). Sensitive PCR proto-
cols have been developed and validated to amplify
serogroup-specific polysialyltransferase genes, and the
variable regions of porA and fetA from culture negative
specimen (data not shown). The discriminatory power of
the typing methods was assessed by using the numeric
index of the discriminatory ability derived from the
Simpson index of diversity (24). The 95% confidence
intervals (CIs) for the numeric indices were calculated as
described by Grundmann et al. (25).
SaTScan Spatiotemporal Analysis
Information about SaTScan version 5.1.1 software is
available at http://www.satscan.org. The program applies a
likelihood function to circular windows originating at
defined locations of increasing size and compares
observed and expected case numbers inside and outside the
scan window to detect clusters that are least likely to have
occurred by chance. The statistical significance for each
cluster is obtained through Monte Carlo hypothesis testing,
i.e., results of the likelihood function are compared for a
large number of random replications of the dataset gener-
ated under the null hypothesis. In this study, cases were
assumed to be Poisson distributed in each location and the
program’s space-time scan statistic was applied. A user-
friendly interface was programmed in Visual Basic for
Applications, operating from within the database of
NRZM: it handled the automatic data transfer to SaTScan
and the creation of concise reports after completion of the
analysis. Duplicate samples were identified and excluded
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pling was defined as time of illness and the county of res-
idence, derived from the postcode, was used as place. The
date of submission to NRZM was used if the date of sam-
pling could not be determined (in 2.5% of all cases).
Spatiotemporal scanning was initiated at the centroids of
the 439 German counties. These represent intermediate
administrative units between the German states and the
local levels (Gemeinden) and vary in size and population
(there are 35,846–3,392,425 inhabitants/county). Acounty,
which can also be a larger town, is the smallest public
health unit. The maximum spatial cluster size was chosen
to correspond to 7% of the German population
(5,777,219). The maximal temporal cluster size was set to
30 days. Age-adjusted scans were performed with age
groups >18 years of age and <18 years of age as a covari-
ate. Adjustments for missing data were made according to
the program’s user manual to account for counties that did
not refer samples to NRZM yet reported cases to the
Robert Koch-Institute (the central federal German institu-
tion responsible for disease control and prevention).
Clusters were considered significant for p values ≤0.05.
Each finetype was analyzed separately.
Geographic Maps
Latitude and longitude coordinates (map date WSG 84)
of the centroids of each German county and age-stratified
census data of the year 2003 were obtained from GfK
Macon (Waghäusel, Germany). Maps were generated and
edited with the programs Regiograph 8 (GfK Macon) and




We analyzed data from 1,616 patients who contracted
IMD in Germany from December 2001 through June 2005.
Geographic data were inferred successfully from the 5-
digit postcode for all patients. Complete finetyping results
(serogroup: P1.VR1,VR2:FVR1) were available for all
patients. Arank-abundance plot of all finetypes found dur-
ing the study period indicated the diversity of pathogenic
meningococci (Figure 1). The proportion of persons <18
years of age was 74.1%. The serogroup distribution was
65.7%, 28.8%, 3.1%, 1.9%, and 0.3% for serogroups B, C,
Y, W135, and 29E, respectively. One case each was caused
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(26). Atotal of 33, 69, and 66 variants of PorAVR1, PorA
VR2, and FetA, respectively, were identified. The number
of unique combinations of serogroups PorA VR1, PorA
VR2, and FetA VR was 383. FetA typing increased the
number of finetypes 2.3-fold compared with the number of
serogroup PorA VR1 and PorA VR2 combinations alone
(167 distinct types). After removing all but 1 strain per
cluster from the complete set of data, we determined the
numeric index of the discriminatory ability of our typing
procedure. Its value for serogroup:PorA typing was 0.930
(95% CI 0.923–0.937) compared with 0.963 (95% CI
0.959–0.968) for serogroup:PorA:FetA typing. The addi-
tion of FetA typing increased the discriminatory power of
our typing procedure.
Cluster Analysis
SaTScan analysis was applied separately to each fine-
type present more than once in the historic dataset (134
finetypes) to identify clustering of meningococcal disease
in space and time to a degree beyond that expected by
chance alone (Table). Analysis identified 26 clusters that
included 68 cases (4.2% of all cases). The maximum num-
ber of patients per cluster was 10. The median duration of
the clusters was 4.0 days (range <1–24 days) and the medi-
an interval between the first and the second case was also
4.0 days (range <1–23 days). The median population with-
in the scan windows imposed by SaTScan was 475,011
(range 42,665–5,441,714). In 76.9% of the clusters, only 2
patients were assigned to a cluster. Figure 2 shows the ret-
rospective identification of a cluster of the finetype
C:P1.5,2:F3–3 (cluster 10, Table).
Adjustment for Potential Confounders
The following potentially confounding variables were
evaluated. Scans were adjusted for age because most cases
occurred in persons <18 years of age (74.1%), the propor-
tion of which was nonhomogeneously distributed per
county (range 12%–26%, data not shown). The date of
birth was missing for 8 patients (0.4%), who were there-
fore excluded from the adjusted scan. Only 1 cluster iden-
tified in the nonadjusted scan was assigned a p value >0.05
after age-adjustment (cluster 16, Table). Age did not sub-
stantially confound the results of the scan.
Underreporting to NRZM by some counties was
addressed. For cases submitted in 2003, we performed
SaTScan analysis excluding 66 counties identified as hav-
ing cases of IMD reported to the Robert Koch-Institute but
not to NRZM. The adjusted scan resulted in slight changes
in the p values of detected clusters compared with the
unadjusted scan but detected the same clusters (data not
shown).
Discussion
Our study quantified the proportion of IMD cases that
occurred in clusters in a large central European country in
a period of 42 months. The following technical prerequi-
sites permitted this large-scale investigation: free availabil-
ity of the cluster detection software SaTScan,
implementation of an automatic data transfer between our
database and SaTScan, availability of data regarding time
and place of occurrence of IMD, and state-of-the-art high-
ly discriminatory finetyping techniques for the infectious
agent in question.
The proportions of different antigenic profiles of
meningococci represented by finetypes are subject to tem-
poral and spatial changes because of constant interaction
with host immunity (27). Compared with sequence types
obtained by MLST,  PorAand FetAfinetypes are expected
to fluctuate to a greater extent over time. The application
of PorAand FetAfinetyping for cluster analysis is warrant-
ed because of its consistency within clusters appearing for
days or weeks. Exceptions exist, e.g., an outbreak of
meningococci differing in its ability to express porA has
been reported (28). However, this phenomenon would not
affect cluster detection by our approach because we used
sequence-based typing. We detected 1 epidemiologically
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Figure 1. Distribution of 383 finetypes included in the present
study (1,616 patients). The most common finetype (B:P1.7–
2,4:F.1–5) accounted for 12.3% of the cases.related cluster in which strains did not uniformly contain
the fetA gene (cluster 11, Table). In general, we believe that
these examples represent exceptions. MLST is probably
not suitable for a timely national laboratory surveillance of
clusters of meningococcal disease because of its consider-
able requirement for resources. The dataset reported here
is the first comprehensive application of FetA typing,
which was introduced as an alternative marker for
meningococci in 2003 (3). FetA typing has proven to be
reliable and easy to use. Moreover, it increased the dis-
criminatory power of our typing procedure. The results of
this study thus support the extended use of FetA sequence
typing.
SaTScan was chosen because it is the most thoroughly
evaluated software for detecting spatiotemporal clusters of
infectious diseases. Application of a Poisson distribution to
the epidemiology of a rare disease such as IMD is appro-
priate, although in practice the null hypothesis (i.e., com-
plete spatial randomness) cannot be expected to be true
even if no clusters of disease exist for a given spatiotem-
poral expanse. SaTScan serves as a tool that directs the
attention of its user to anomalous case distributions. The p
values are automatically adjusted for the multiple testing
stemming from repeated evaluations of different potential
clusters during hypothesis testing.
Hoebe et al. applied a global clustering test (space-time
nearest neighbor analysis) to different serosubtypes of
meningococci and found statistical evidence for clustering
in 6 of 25 clusters reported by the Dutch Inspectorate of
Health Care (10). However, connections of >2 cases could
not be demonstrated beyond chance. Since only phenotyp-
ic typing was performed, the analysis was restrained by a
considerable proportion of nontypeable isolates. In con-
trast to the Dutch study, we included both viable strains
and sterile specimens in our investigation. Only fully-
typed strains and DNA were evaluated for the existence of
spatiotemporal clusters. Since we used a cluster detection
test rather than a global clustering test, we were able to
pinpoint clusters of meningococcal disease even for rare
finetypes in space and time. The detection of the presented
clusters as such did not depend on the attentiveness of pub-
lic health workers. Spatiotemporal proximity could be
shown for up to 10 patients (cluster 24, Table). Similar to
findings of other studies (29), most clusters had only 2
patients.
The temporal settings of our scans were defined accord-
ing to results from earlier retrospective cluster studies. An
American analysis (30) found that 73% of secondary cases
appeared <14 days after the index case. In France, 72% of
secondary cases occurred in the first week after the first
case (5). A British survey determined the median intervals
between the index case and the second case to be 1.5, 5, or
23 days, depending on the setting of the cluster (house-
hold, school, or university) (29). Thus, a maximal tempo-
ral window of 30 days should detect most of the existing
clusters, although the time between the first and the second
case may rarely exceed this temporal limit.
Two spatially confined immunization campaigns were
conducted after outbreaks of IMD caused by ET-15
meningococci. Our analysis detected 2 clusters represent-
ing each of them (clusters 11 and 19). The first campaign
targeted a single county in North-Rhine-Westphalia; the
second one comprised only a few boroughs within a coun-
ty in Bavaria (31). Theoretically, spatially uneven vaccine
coverage could introduce a regional bias into our analysis,
e.g., by creating areas with low carriage rates (herd protec-
tion). Because of the low number and confined nature of
the campaigns, a possible bias was not assessed but is like-
ly negligible. A general recommendation for vaccination
against serogroup C disease in Germany was made in
2006, i.e., after this study. Previously, only the State of
Saxony had a general recommendation. However, reim-
bursement of costs was not guaranteed there, and precise
numbers of vaccinees are not available. One also has to
consider that most cases of meningococcal disease in
Germany are not preventable by vaccination.
Most clusters of meningococcal disease occur in house-
holds or social units that provide educational services in
workplaces, and through other forms of social interaction.
To curtail computing time while providing an acceptable
geographic resolution, counties represented the smallest
Invasive Meningococcal Disease, Germany
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Figure 2. Retrospective identification of a cluster (cluster 10) of the
finetype C:P1.5,2:F3-3 in 3 temporal planes using SaTScan (11).
Planes A, B, and C represent consecutive temporal windows of 30
days in 2003. Cases with the finetype in question are shown by
dark ovals defined by the dimensions longitude, latitude, and time.
Although planes A and C do not show spatial clustering, plane B
shows an accumulation of 4 cases in 2 counties within a circle
encompassing a population of 339,185 (radius 28.78 km, p =
0.004; marked by a gray oval). Counties of Germany are shaded
according to their population density (darker indicates a higher
population density).geographic units in our analysis. The variable size of the
counties leads to fewer possible cluster locations evaluat-
ed in the area of large counties. The increased geographic
aggregation in larger counties may also reduce the power
to detect small clusters. However, since maximal spatial
cluster size was chosen to correspond to 7% of the German
population, detection of clusters spanning neighboring
counties was warranted in all positions of our grid (e.g.,
Berlin’s population plus that of the counties encircling it
comprise <7% of the population of Germany). Performing
cluster analyses on the basis of the patient’s residence may
not always reflect the area of the social network where
acquisition of IMD occurred. Infection might be contract-
ed at locations other than the one suggested by the post-
code, e.g., at gatherings outside the county of residence.
Thus, a few supraregional clusters might have been missed
by our approach.
The proportion of patients involved in clusters in
Germany was 4.2% (95% CI 3%–5.3%). Interpretation of
this figure must consider that not all cases of IMD are
assessed at NRZM. Conversely, all clusters reported here-
in were verified by finetyping. In 42 months, 26 clusters
were detected. In France, 28 clusters of meningococcal
disease were identified within 2 years, as shown by a
household and institution survey. A total of 4.5% of all
cases were either coprimary cases or secondary cases (5).
Historic analysis comprising nearly 40 years based on
Israeli health ministry investigations suggested that 13%
of all cases were involved in outbreaks (32). In England
and Wales, 0.5% of all cases investigated were secondary
cases among close family and household contacts (4).
Approximately 20 clusters occurred in England and Wales
per year in preschool and school settings (33). Thus, epi-
demiologic surveys suggest that only a few cases are
involved in clusters of IMD. This finding is supported by
the results of our analysis.
The combined use of medical informatics and molecu-
lar laboratory techniques recently assisted detection of a
methicillin-resistant  Staphylococcus aureus outbreak in
the hospital setting (34). The almost seamless integration
of SaTScan into the database of NRZM will enable us to
implement an early-warning system embedded in a geo-
graphic information system. This will support public
health investigation of a serious community-acquired dis-
ease. We are currently evaluating the benefits of prospec-
tive cluster analyses and their immediate reporting to
public health officials for management of IMD.
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